Amgen: Optimizing LDL-C Management in Patients Undergoing Revascularization: More Than Just the Metal

      
Prescribing Information

 



FACULTY
 

Ziad Ali Ziad A. Ali, MD 
Columbia University Medical Center 
New York City, NY
Aloke Finn, MD Aloke Finn, MD 
CVPath Institute
Gaithersburg, MD



AGENDA
 

•    ACS Patient Case: Role of the IC, what happens after PCI, and what is the risk of another CV event or rehospitalization

•    Pathogenesis of Acute Coronary Syndrome

•    Guideline Recommended Lipid Lowering Therapy for Recent MI Patients

•    Clinical Studies Supporting LDL-C Lowering in Patients With Recent-MI

•    Healthcare Team Approach to Optimize Patient Outcomes

 


 

This program was supported by: Amgen - Optimizing LDL-C Management in Patients Undergoing Revascularization: More Than Just the Metal